Patent · US Active

Antibodies to cytokine receptor ZCYTOR17

US8309692B2 · kind B2 · utility

6Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2011
Grant dateNov 13, 2012
Priority date
Expiry dateApr 20, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17, a novel cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zcytor17, are located on chromosome 5, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.